A trial to investigate the duration for which rheumatoid arthritis patients treated with subcutaneous methotrexate because of an unsatisfactory response to oral methotrexate remain on methotrexate monotherapy
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2014
Price : $35 *
At a glance
- Drugs Methotrexate (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 14 Jul 2014 New trial record
- 14 Jun 2014 Results presented at the 15th Annual Congress of the European League Against Rheumatism.
- 20 May 2014 According to an Antares Pharma media release, the results of this trial will be presented at the 2014 European League Against Rheumatism Annual Congress.